(Q33767866)
Statements
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group (English)
G J Bubley
M Carducci
W Dahut
N Dawson
D Daliani
M Eisenberger
W D Figg
B Freidlin
G Hudes
M Hussain
R Kaplan
C Myers
W Oh
D P Petrylak
E Reed
B Roth
O Sartor
H Scher
J Simons
V Sinibaldi
E J Small
M R Smith
D L Trump
1 November 1999